Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, 1990-2001

Breast

Volumn 16, Issue 6, 2007, Pages 606-614

  Siesling, S ^a   van de Poll Franse, L V ^b   Jobsen, J J ^c   Repelaer van Driel, O J ^d   Voogd, A C ^e  

^a Integraal Kankercentrum Stedendriehoek Twente   (Netherlands)

^b The Netherlands   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d MÁXIMA MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Breast conserving surgery; Cancer registry; Hospital volume; Radiotherapy; Regional variation

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NETHERLANDS; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT PLANNING; TREND STUDY; TUMOR VOLUME;

EID: 35048891310     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.05.004     Document Type: Article

References (34)

1. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
2. van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92 (2000) 1143-1150
3. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
4. NIH consensus conference. Treatment of early-stage breast cancer. JAMA 265 3 (1991) 391-395
5. Du X., Freeman Jr. D.H., and Syblik D.A. What drove changes in the use of breast conserving surgery since the early 1980s? The role of the clinical trial, celebrity action and an NIH consensus statement. Breast Cancer Res Treat 62 (2000) 71-79
6. Rutgers E.J., Nortier J.W., Tuut M.K., et al. Dutch Institute for Healthcare Improvement guideline, "Treatment of breast cancer". Ned Tijdschr Geneeskd 146 (2002) 2144-2151
7. Voogd A.C., Repelaer van Driel O.J., Roumen R.M., Crommelin M.A., van Beek M.W., and Coebergh J.W. Changing attitudes towards breast-conserving treatment of early breast cancer in the south-eastern Netherlands: results of a survey among surgeons and a registry-based analysis of patterns of care. Eur J Surg Oncol 23 (1997) 134-138
8. Nattinger A.B., Gottlieb M.S., Veum J., Yahnke D., and Goodwin J.S. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 326 (1992) 1102-1107
9. Skinner K.A., Helsper J.T., Deapen D., Ye W., and Sposto R. Breast cancer: do specialists make a difference?. Ann Surg Oncol 10 (2003) 606-615
10. Sainsbury R., Haward B., Rider L., Johnston C., and Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 345 (1995) 1265-1270
11. Roohan P.J., Bickell N.A., Baptiste M.S., Therriault G.D., Ferrara E.P., and Siu A.L. Hospital volume differences and five-year survival from breast cancer. Am J Public Health 88 (1998) 454-457
12. Visser O., Coebergh J.W.W., Dijck van J.A.A.M., and Siesling S. Incidence of cancer in The Netherlands 1998 (2002), Vereniging van Integrale Kankercentra, Utrecht
13. In: Hermanek P., and Sobin L.H. (Eds). UICC: TNM classification of malignant tumours. 4th ed (1987), Springer, Berlin 94-99
14. Schouten L.J., Hoppener P., van den Brandt P.A., Knottnerus J.A., and Jager J.J. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol 22 (1993) 369-376
15. 〈http://www.ikcnet.nl/uploaded/FILES/Landelijk/cijfers/Incidentie%202003/〉.
16. Elkhuizen P.H., van de Vijver M.J., Hermans J., Zonderland H.M., van de Velde C.J., and Leer J.W. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 40 (1998) 859-867
17. Haffty B.G., Harrold E., Khan A.J., et al. Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet 359 (2002) 1471-1477
18. Veronesi U., Salvadori B., Luini A., et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer 31A (1995) 1574-1579
19. Louwman W.J., Janssen-Heijnen M.L., Houterman S., et al. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer 41 (2005) 779-785
20. Smith B.D., Gross C.P., Smith G.L., Galusha D.H., Bekelman J.E., and Haffty B.G. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 98 (2006) 681-690
21. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000;355:1757-70.
22. Voogd A.C., Peterse J.L., Crommelin M.A., et al. Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch study group on local recurrence after breast conservation (BORST). Eur J Cancer 35 (1999) 1828-1837
23. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
24. Nold R.J., Beamer R.L., Helmer S.D., and McBoyle M.F. Factors influencing a woman's choice to undergo breast-conserving surgery versus modified radical mastectomy. Am J Surg 180 (2000) 413-418
25. Vulto A.J., Lemmens V.E., Louwman M.W., Janssen-Heijnen M.L., Poortmans P.H., Lybeert M.L., et al. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002. Cancer 106 (2006) 2734-2742
26. Brekelmans C.T., Voogd A.C., Botke G., van Geel B.N., Rodrigus P., Rutgers E.J., et al. Family history of breast cancer and local recurrence after breast-conserving therapy. The Dutch study group on local recurrence after breast conservation (BORST). Eur J Cancer 35 (1999) 620-626
27. Voogd A.C., Nielsen M., Peterse J.L., et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 19 (2001) 1688-1697
28. Jobsen J.J., Meerwaldt J.H., and van der Palen J. Family history in breast cancer is not a prognostic factor?. Breast 9 (2000) 83-87
29. Nattinger A.B., Hoffmann R.G., Kneusel R.T., and Schapira M.M. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet 356 (2000) 1148-1153
30. Nattinger A.B., Hoffmann R.G., Howell-Pelz A., and Goodwin J.S. Effect of Nancy Reagan's mastectomy on choice of surgery for breast cancer by US women. JAMA 279 (1998) 762-766
31. Street Jr. R.L., and Voigt B. Patient participation in deciding breast cancer treatment and subsequent quality of life. Med Decision Making 17 (1997) 298-306
32. Keating N.L., Guadagnoli E., Landrum M.B., Borbas C., and Weeks J.C. Treatment decision making in early-stage breast cancer: should surgeons match patients' desired level of involvement?. J Clin Oncol 20 (2002) 1473-1479
33. Janz N.K., Wren P.A., Copeland L.A., Lowery J.C., Goldfarb S.L., and Wilkins E.G. Patient-physician concordance: preferences, perceptions, and factors influencing the breast cancer surgical decision. J Clin Oncol 22 (2004) 3091-3098
34. Laliberte L., Fennell M.L., and Papandonatos G. The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer. Med Care 43 (2005) 471-479